Published in J Exp Med on February 01, 1999
Programming dendritic cells to induce T(H)2 and tolerogenic responses. Nat Immunol (2010) 2.29
New paradigms in type 2 immunity. Science (2012) 2.27
Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med (2008) 2.25
Cyclic AMP: master regulator of innate immune cell function. Am J Respir Cell Mol Biol (2008) 2.00
Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivo. J Exp Med (2014) 1.59
Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest (2004) 1.58
Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci U S A (2010) 1.49
Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens. PLoS One (2009) 1.46
Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin. Nat Med (2016) 1.45
Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest (2001) 1.43
Cholera toxin and heat-labile enterotoxin activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cyclic AMP-dependent pathway. Infect Immun (2002) 1.20
Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Infect Immun (2003) 1.13
Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases. PLoS Pathog (2013) 1.07
Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol (2002) 1.05
Colonization of C57BL/6J and BALB/c wild-type and knockout mice with Helicobacter pylori: effect of vaccination and implications for innate and acquired immunity. Infect Immun (2003) 1.04
Cholera toxin inhibits IL-12 production and CD8alpha+ dendritic cell differentiation by cAMP-mediated inhibition of IRF8 function. J Exp Med (2009) 1.03
Signaling of c-kit in dendritic cells influences adaptive immunity. Ann N Y Acad Sci (2010) 1.00
Plasmid vectors encoding cholera toxin or the heat-labile enterotoxin from Escherichia coli are strong adjuvants for DNA vaccines. J Virol (2002) 1.00
Distinct cytokine regulation by cholera toxin and type II heat-labile toxins involves differential regulation of CD40 ligand on CD4(+) T cells. Infect Immun (2001) 1.00
Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells. Infect Immun (1999) 0.99
CD47 ligation selectively downregulates human interleukin 12 production. J Exp Med (1999) 0.99
The multikinase inhibitor sorafenib reverses the suppression of IL-12 and enhancement of IL-10 by PGE₂ in murine macrophages. Int Immunopharmacol (2010) 0.97
Differential requirements for protection against mucosal challenge with Francisella tularensis in the presence versus absence of cholera toxin B and inactivated F. tularensis. J Immunol (2009) 0.97
Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells. Immunology (2002) 0.97
Type I cytokine profiles of human naïve and memory B lymphocytes: a potential for memory cells to impact polarization. Immunology (2006) 0.97
Interleukin-12 as an adjuvant for induction of protective antibody responses. Cytokine (2010) 0.94
Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences. Immunology (2002) 0.92
IL-12 as a therapeutic target for pharmacological modulation in immune-mediated and inflammatory diseases: regulation of T helper 1/T helper 2 responses. Br J Pharmacol (1999) 0.91
Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions. Infect Immun (2003) 0.89
Cholera toxin adjuvant promotes a balanced Th1/Th2/Th17 response independently of IL-12 and IL-17 by acting on Gsα in CD11b⁺ DCs. Mucosal Immunol (2014) 0.88
Cholera toxin impairs the differentiation of monocytes into dendritic cells, inducing professional antigen-presenting myeloid cells. Infect Immun (2010) 0.84
The B subunit of Escherichia coli heat-labile enterotoxin induces both caspase-dependent and -independent cell death pathways in CD8+ T cells. Infect Immun (2004) 0.83
Nasal delivery of antigen with the B subunit of Escherichia coli heat-labile enterotoxin augments antigen-specific T-cell clonal expansion and differentiation. Infect Immun (2004) 0.82
Phosphodiesterase 4 inhibition in the treatment of psoriasis, psoriatic arthritis and other chronic inflammatory diseases. Dermatol Ther (Heidelb) (2013) 0.81
Immunomodulatory effects of Yersinia pestis lipopolysaccharides on human macrophages. Clin Vaccine Immunol (2009) 0.80
Cocoa Diet Prevents Antibody Synthesis and Modifies Lymph Node Composition and Functionality in a Rat Oral Sensitization Model. Nutrients (2016) 0.79
Tetanus toxin fragment C expressed in live Salmonella vaccines enhances antibody responses to its fusion partner Schistosoma haematobium glutathione S-transferase. Infect Immun (2000) 0.79
Cholera toxin directly enhances IL-17A production from human CD4+ T cells. J Immunol (2013) 0.78
Toxins-useful biochemical tools for leukocyte research. Toxins (Basel) (2010) 0.78
Interleukin-4- and NACHT, LRR and PYD domains-containing protein 3-independent mechanisms of alum enhanced T helper type 2 responses on basophils. Immunology (2016) 0.77
Shaping immune responses through the activation of dendritic cells' P2 receptors. Purinergic Signal (2006) 0.76
Endotoxic shock-expanded murine CD11c low CD45RB + regulatory dendritic cells modulate inflammatory T cell responses through multiple mechanisms. Sci Rep (2015) 0.76
Increased antigen specific T cell numbers in the absence of altered migration or division rates as a result of mucosal cholera toxin administration. PLoS One (2013) 0.75
Inhibition of T-cell response by Escherichia coli heat-labile enterotoxin-treated epithelial cells. Infect Immun (2000) 0.75
Mechanisms of Cholera Toxin in the Modulation of TH17 Responses. Crit Rev Immunol (2015) 0.75
Low doses of cholera toxin and its mediator cAMP induce CTLA-2 secretion by dendritic cells to enhance regulatory T cell conversion. PLoS One (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature (1997) 16.28
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 6.16
Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol Rev (1992) 5.15
Dendritic cells in the T-cell areas of lymphoid organs. Immunol Rev (1997) 4.41
The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med (1996) 3.82
Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods (1996) 3.80
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol (1995) 3.76
Mechanism of suppression of cell-mediated immunity by measles virus. Science (1996) 3.55
Reversibility of T helper 1 and 2 populations is lost after long-term stimulation. J Exp Med (1996) 3.41
Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes. J Exp Med (1989) 3.06
Prostaglandin-E2 is a potent inhibitor of human interleukin 12 production. J Exp Med (1995) 2.98
Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol (1995) 2.87
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A (1994) 2.82
Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity (1995) 2.64
Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med (1993) 2.62
Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med (1998) 2.55
Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J Immunol (1984) 2.51
Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today (1997) 2.44
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci U S A (1998) 2.33
Proinflammatory and immunoregulatory functions of interleukin-12. Int Rev Immunol (1998) 2.32
Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med (1997) 2.31
Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med (1997) 2.09
Cholera toxin stimulates IL-1 production and enhances antigen presentation by macrophages in vitro. J Immunol (1991) 2.08
Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun (1982) 2.08
A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc Natl Acad Sci U S A (1997) 2.07
Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells. Proc Natl Acad Sci U S A (1996) 2.06
Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol (1998) 2.05
Cholera toxin inhibits the T-cell antigen receptor-mediated increases in inositol trisphosphate and cytoplasmic free calcium. Proc Natl Acad Sci U S A (1986) 1.98
Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest (1997) 1.94
Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J Exp Med (1990) 1.81
Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells, analyzed at the single-cell level. J Exp Med (1996) 1.80
Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding. J Immunol (1994) 1.72
In vivo production and function of IL-12 p40 homodimers. J Immunol (1997) 1.72
Impaired mucosal immune responses in interleukin 4-targeted mice. J Exp Med (1995) 1.71
Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon. Infect Immun (1994) 1.71
Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J Infect Dis (1996) 1.68
Characterization of IL-12 receptor beta1 chain (IL-12Rbeta1)-deficient mice: IL-12Rbeta1 is an essential component of the functional mouse IL-12 receptor. J Immunol (1997) 1.66
Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci U S A (1994) 1.66
The role of Stat4 in species-specific regulation of Th cell development by type I IFNs. J Immunol (1998) 1.65
Factors involved in the differentiation of TGF-beta-producing cells from naive CD4+ T cells: IL-4 and IFN-gamma have opposing effects, while TGF-beta positively regulates its own production. J Immunol (1998) 1.56
The mechanism of cholera toxin adjuvanticity. Res Immunol (1998) 1.51
The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand J Immunol (1991) 1.51
Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responses. Infect Immun (1996) 1.50
High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol (1996) 1.49
Immunobiology of interleukin-12. Immunol Res (1998) 1.48
Inhibition of murine lymphocyte proliferation by the B subunit of cholera toxin. J Immunol (1987) 1.39
Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein Ag and cholera toxin. J Immunol (1994) 1.34
Cholera toxin promotes B cell isotype differentiation. J Immunol (1989) 1.32
Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur J Immunol (1993) 1.29
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins. Infect Immun (1995) 1.29
Treatment with homodimeric interleukin-12 (IL-12) p40 protects mice from IL-12-dependent shock but not from tumor necrosis factor alpha-dependent shock. Infect Immun (1997) 1.25
IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann N Y Acad Sci (1996) 1.24
Alloantigen-reactive Th1 development in IL-12-deficient mice. J Immunol (1998) 1.23
The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit Rev Immunol (1995) 1.23
Cholera toxin enhances alloantigen presentation by cultured intestinal epithelial cells. Scand J Immunol (1993) 1.21
The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression. J Immunol (1997) 1.21
Inhibition of IL-12 production by thalidomide. J Immunol (1997) 1.20
Morphologic and functional alterations of mucosal T cells by cholera toxin and its B subunit. J Immunol (1995) 1.19
Cellular basis of immunomodulation by cholera toxin in vitro with possible association to the adjuvant function in vivo. J Immunol (1989) 1.18
Characterization of the receptor for cholera toxin and Escherichia coli heat-labile toxin in rabbit intestinal brush borders. Biochem J (1986) 1.17
Comparison of receptors for cholera and Escherichia coli enterotoxins in human intestine. Gastroenterology (1985) 1.17
Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. J Immunol (1997) 1.15
Oral tolerance. J Clin Immunol (1998) 1.11
Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex. J Immunol (1998) 1.09
Regulation of transforming growth factor-beta production by interleukin-12. Eur J Immunol (1997) 1.09
Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance. Immunology (1997) 1.04
IFN-gamma-independent production of IL-12 during murine endotoxemia. J Immunol (1996) 1.02
cAMP up-regulates IL-4 and IL-5 production from activated CD4+ T cells while decreasing IL-2 release and NF-AT induction. Int Immunol (1994) 1.01
Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med (1997) 1.00
Effects of cholera toxin adjuvant on IgE antibody response to orally or nasally administered ovalbumin. Vaccine (1994) 0.96
Cholera toxin acts as a potent adjuvant for the induction of cytotoxic T-lymphocyte responses with non-replicating antigens. Immunology (1994) 0.95
Cholera toxin inhibits resting human T cell activation via a cAMP-independent pathway. J Immunol (1989) 0.93
Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages. J Immunol (1996) 0.93
Cholera toxin and cholera toxin B subunit induce IgA switching through the action of TGF-beta 1. J Immunol (1998) 0.91
The immunological consequences of feeding cholera toxin. I. Feeding cholera toxin suppresses the induction of systemic delayed-type hypersensitivity but not humoral immunity. Immunology (1989) 0.89
Inhibition of class II major histocompatibility complex antigen processing by Escherichia coli heat-labile enterotoxin requires an enzymatically active A subunit. Infect Immun (1998) 0.86
Anti-dinitrophenyl antibody production in strain 13 guinea pigs fed or sensitized with dinitrochlorobenzene. J Immunol (1975) 0.84
Inhibition of murine T cell activation by cholera toxin B subunit is not mediated through the phosphatidylinositol second messenger system. J Immunol (1993) 0.83
Inhibition of human interleukin-12 production by pentoxifylline. Immunology (1997) 0.83
The immunological consequences of feeding cholera toxin. II. Mechanisms responsible for the induction of oral tolerance for DTH. Immunology (1989) 0.82
Induction of gut mucosal immune responses: importance of genetic background and Th1/Th2 cross-regulation. Scand J Immunol (1998) 0.81
Evidence for protein kinase C pathway in the response of human peripheral blood mononuclear cells to cholera toxin. Cell Immunol (1996) 0.78
Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res (1993) 10.98
Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) (2008) 9.45
Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA (1999) 9.18
Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity (1995) 7.08
Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med (1995) 6.89
IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity (1996) 6.16
Type IV pili, transient bacterial aggregates, and virulence of enteropathogenic Escherichia coli. Science (1998) 5.49
Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab (2001) 4.53
Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells. J Exp Med (1999) 3.79
Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J Appl Physiol (1985) (2000) 3.54
Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med (2000) 3.43
Seeing the herpesvirus capsid at 8.5 A. Science (2000) 3.35
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. JAMA (1997) 3.27
A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci U S A (1996) 3.07
Detection of methicillin-resistant staphylococci by using the polymerase chain reaction. J Clin Microbiol (1992) 3.01
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia (2003) 3.00
Unique functions of CD11b+, CD8 alpha+, and double-negative Peyer's patch dendritic cells. J Immunol (2001) 2.93
Characterization of vancomycin resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob Agents Chemother (1989) 2.83
Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol (1995) 2.71
Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. J Exp Med (1996) 2.68
Complete genome sequence of the shrimp white spot bacilliform virus. J Virol (2001) 2.58
Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med (1993) 2.55
Assembly of VP26 in herpes simplex virus-1 inferred from structures of wild-type and recombinant capsids. Nat Struct Biol (1995) 2.51
Spinal cord stimulation facilitates functional walking in a chronic, incomplete spinal cord injured. Spinal Cord (2002) 2.47
Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension (2001) 2.42
Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc (2000) 2.35
Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge. Proc Natl Acad Sci U S A (1998) 2.33
Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol Carcinog (1995) 2.25
Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med (1997) 2.09
Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med (2001) 2.08
Enteropathogenic Escherichia coli: identification of a gene cluster coding for bundle-forming pilus morphogenesis. J Bacteriol (1996) 2.08
Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest (1996) 2.07
Electron correlation effects in resonant inelastic X-ray scattering of NaV2O5. Phys Rev Lett (2002) 2.06
Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol (2001) 2.03
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension (2000) 1.96
An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale. AJNR Am J Neuroradiol (2008) 1.80
Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77
The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12. J Clin Invest (1998) 1.77
Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J Exp Med (1993) 1.75
Mutations in the protein kinase A R1alpha regulatory subunit cause familial cardiac myxomas and Carney complex. J Clin Invest (2000) 1.72
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens (2004) 1.71
Long-term controlled normoglycemia in diabetic non-human primates after transplantation with hCD46 transgenic porcine islets. Am J Transplant (2009) 1.69
Effect of rehabilitation tasks on organization of movement after stroke. Am J Occup Ther (1999) 1.64
Expression of zebrafish bHLH genes ngn1 and nrd defines distinct stages of neural differentiation. Dev Dyn (1998) 1.63
Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J Immunol (2000) 1.59
MDM2 regulates MYCN mRNA stabilization and translation in human neuroblastoma cells. Oncogene (2011) 1.59
Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther (2010) 1.59
Comorbidity profiles among patients with bullous pemphigoid: a nationwide population-based study. Br J Dermatol (2011) 1.57
Tonotopic organization of auditory cortical fields delineated by parvalbumin immunoreactivity in macaque monkeys. J Comp Neurol (1997) 1.57
Quorum sensing differentially regulates Pseudomonas aeruginosa type VI secretion locus I and homologous loci II and III, which are required for pathogenesis. Microbiology (2009) 1.56
Neurogenesis in adolescent brain is potently inhibited by ethanol. Neuroscience (2005) 1.56
The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc Natl Acad Sci U S A (2000) 1.55
Repeat transthoracic endoscopic sympathectomy for palmar and axillary hyperhidrosis. Surg Endosc (2000) 1.53
An assessment of air toxics in Minnesota. Environ Health Perspect (2000) 1.52
Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol (1998) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
First observation of the decays B(0) → D(+)K(-)π(+)π(-) and B(-) → D(0)K(-)π(+)π(-). Phys Rev Lett (2012) 1.50
High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol (1996) 1.49
Dietary potassium intake and risk of stroke in US men and women: National Health and Nutrition Examination Survey I epidemiologic follow-up study. Stroke (2001) 1.48
Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study. Br J Dermatol (2001) 1.46
Requirements for the maintenance of Th1 immunity in vivo following DNA vaccination: a potential immunoregulatory role for CD8+ T cells. J Immunol (2000) 1.45
Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations. Cancer (2000) 1.44
Cloning and characterization of a gene required for the secretion of extracellular enzymes across the outer membrane by Xanthomonas campestris pv. campestris. J Bacteriol (1992) 1.44
Validity of physicians' self-reports of cardiovascular disease risk factors. Ann Epidemiol (1993) 1.43
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Metallic "ferroelectricity" in the pyrochlore Cd2Re2O7. Phys Rev Lett (2004) 1.42
DNA vaccines: a key for inducing long-term cellular immunity. Curr Opin Immunol (2000) 1.42
Unmasking the dynamic interplay between efflux transporters and metabolic enzymes. Int J Pharm (2004) 1.41
Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease. Epidemiol Infect (2013) 1.41
Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: evidence for a role of the envelope. J Virol (1999) 1.40
Apoptosis induced by HIV-1 infection of the central nervous system. J Clin Invest (1996) 1.40
Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. Circulation (2001) 1.38
Selective suppression of IL-12 production by chemoattractants. J Immunol (2000) 1.37
Cytokine expression in the alkali-burned cornea. Curr Eye Res (1997) 1.35
CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J Immunol (1998) 1.32
Mucosal immunity and inflammation. I. Mucosal dendritic cells: their specialized role in initiating T cell responses. Am J Physiol (1999) 1.31
Broadband ultrasound attenuation signals depend on trabecular orientation: an in vitro study. Osteoporos Int (1993) 1.30
Development and evaluation of biocompatible films of polytetrafluoroethylene polymers holding lithium phthalocyanine crystals for their use in EPR oximetry. Biosens Bioelectron (2005) 1.30
Biological characterization of a new radioactive labeling reagent for bacterial penicillin-binding proteins. Antimicrob Agents Chemother (1990) 1.29
Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Differ (2004) 1.29
Potent neutralization of primary human immunodeficiency virus clade C isolates with a synergistic combination of human monoclonal antibodies raised against clade B. J Hum Virol (2001) 1.28
Actin and myosin contribute to mammalian mitochondrial DNA maintenance. Nucleic Acids Res (2011) 1.27
Vertebral fractures in osteoporosis: a new method for clinical assessment. J Clin Densitom (2000) 1.26
Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int (1994) 1.25
Chromosome 9 deletion mapping reveals interferon alpha and interferon beta-1 gene deletions in human glial tumors. Cancer Res (1991) 1.25
Molecular cloning and heterologous expression of a glutathione S-transferase involved in insecticide resistance from the diamondback moth, Plutella xylostella. Insect Biochem Mol Biol (1998) 1.25
Apolipoprotein A-I stimulates AMP-activated protein kinase and improves glucose metabolism. Diabetologia (2007) 1.24
IL-12-deficient mice are defective but not devoid of type 1 cytokine responses. Ann N Y Acad Sci (1996) 1.24
Asynchronous activation of 10 muscle-specific protein (MSP) genes during zebrafish somitogenesis. Dev Dyn (2000) 1.23
Impact of hypertension on health-related quality of life in a population-based study in Shanghai, China. Public Health (2009) 1.23
RmpA regulation of capsular polysaccharide biosynthesis in Klebsiella pneumoniae CG43. J Bacteriol (2010) 1.22
Common and well-documented HLA alleles: 2012 update to the CWD catalogue. Tissue Antigens (2013) 1.22
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases. Chem Biol (2001) 1.22
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol (1994) 1.21
kurtz, a novel nonvisual arrestin, is an essential neural gene in Drosophila. Genetics (2000) 1.21
Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence. Neuroscience (2009) 1.20
The influence of chain length and base sequence on the pharmacokinetic behavior of 99mTc-morpholinos in mice. Q J Nucl Med (2002) 1.18
Understanding sensorimotor feedback through optimal control. Cold Spring Harb Symp Quant Biol (1990) 1.18